Literature DB >> 14716244

Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: follow-up study by magnetic resonance cholangiopancreatography.

Hiroyuki Irie1, Kengo Yoshimitsu, Hitoshi Aibe, Tsuyoshi Tajima, Akihiro Nishie, Tomohiro Nakayama, Daisuke Kakihara, Hiroshi Honda.   

Abstract

OBJECTIVE: The purpose of this study was to elucidate the natural history of branch duct type pancreatic intraductal papillary mucinous tumor (IPMT) by evaluating serial changes in the magnetic resonance cholangiopancreatography (MRCP) findings of patients diagnosed with pancreatic IPMT of branch duct type.
METHODS: Thirty-five patients had branch duct type IPMT, including 9 patients with separate lesions, and underwent initial and follow-up MRCP over a period of more than 12 months. The maximum diameter of the cystic lesion, the presence of associated main pancreatic duct (MPD) dilatation, and the presence of a filling defect were evaluated. Serial changes in these findings were analyzed.
RESULTS: Tumor enlargement on follow-up MRCP was observed in 7 cases. Of the 29 branch duct IPMTs without associated MPD dilatation or a filling defect identified on initial MRCP, only 1 showed gradual tumor enlargement. In 4 cases, the cyst size decreased on follow-up MRCP.
CONCLUSIONS: Branch duct type IPMTs grow slowly and can be monitored without operation provided that the tumor shows no associated MPD dilatation or filling defect.

Entities:  

Mesh:

Year:  2004        PMID: 14716244     DOI: 10.1097/00004728-200401000-00020

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  24 in total

1.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

2.  Dynamic computed tomography findings of malignant intraductal papillary mucinous tumor compared with invasive ductal adenocarcinoma.

Authors:  Toshiro Ozaki; Takeshi Kamura; Yoichi Ajioka; Yoshio Shirai; Isao Kurosaki; Satoshi Yamamoto; Keisuke Sasai
Journal:  Radiat Med       Date:  2007-11-26

3.  CT vs MRCP: optimal classification of IPMN type and extent.

Authors:  Joshua A Waters; C Max Schmidt; Jason W Pinchot; Patrick B White; Oscar W Cummings; Henry A Pitt; Kumar Sandrasegaran; Fatih Akisik; Thomas J Howard; Attila Nakeeb; Nicholas J Zyromski; Keith D Lillemoe
Journal:  J Gastrointest Surg       Date:  2007-10-05       Impact factor: 3.452

Review 4.  Ultrasonographic findings and natural history of intraductal papillary-mucinous neoplasms of the pancreas.

Authors:  Go Kobayashi; Naotaka Fujita; Yutaka Noda; Takashi Obana; Osamu Takasawa
Journal:  J Med Ultrason (2001)       Date:  2008-09-19       Impact factor: 1.314

Review 5.  Clinical aspects of intraductal papillary mucinous neoplasm of the pancreas.

Authors:  Masao Tanaka; Kiichiro Kobayashi; Kazuhiro Mizumoto; Koji Yamaguchi
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

6.  Outcome of long interval radiological surveillance of side branch pancreatic duct-involved intraductal papillary mucinous neoplasm in selected patients.

Authors:  Yazan S Khaled; Muhammed Mohsin; Kavi Fatania; Ada Yee; Robert Adair; Maria Sheridan; Christian Macutkiewicz; Amer Aldouri; Andrew M Smith
Journal:  HPB (Oxford)       Date:  2016-08-30       Impact factor: 3.647

7.  Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysis.

Authors:  Edward S Huang; G Scott Gazelle; Chin Hur
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

8.  Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinico-pathological correlations and surgical indications.

Authors:  Gian Luca Baiocchi; Nazario Portolani; Guido Missale; Carla Baronchelli; Federico Gheza; Massimiliano Cantù; Luigi Grazioli; Stefano M Giulini
Journal:  World J Surg Oncol       Date:  2010-04-07       Impact factor: 2.754

9.  Natural history of asymptomatic pancreatic cystic neoplasms.

Authors:  Gareth Morris-Stiff; Gavin A Falk; Sricharan Chalikonda; R Matthew Walsh
Journal:  HPB (Oxford)       Date:  2012-07-23       Impact factor: 3.647

Review 10.  Natural history of intraductal papillary mucinous neoplasms (IPMN): current evidence and implications for management.

Authors:  Claudio Bassi; Michael G Sarr; Keith D Lillemoe; Howard A Reber
Journal:  J Gastrointest Surg       Date:  2007-12-19       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.